Interleukin-6 gene expression is preferentially restricted in VLA-5-MPC-1- immature but not in VLA-5+MPC-1+ mature myeloma cells

International Journal of Hematology

Volumn 63, Issue 3, 1996, Pages 215-226

  Mihara, Keiichiro ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

IL 6; Immature myeloma cells; MPC 1; VLA 5

Indexed keywords

INTERLEUKIN 6; MESSENGER RNA; VERY LATE ACTIVATION ANTIGEN 5;

ARTICLE; CELL PROLIFERATION; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MYELOMA CELL; PLASMA CELL; PRIORITY JOURNAL;

EID: 0029981704     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/0925-5710(96)00439-2     Document Type: Article

References (23)

1. Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H, Kuramoto A, Kishimoto T. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 1988;332:83-85.
2. Klein B, Zhang XG, Jourdan M, Content J, Houssiau F, Aarden L, Piechaczyk M, Bataille R. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 1989;73:517-526.
3. Petrucci MT, Hata H, Xiao HQ, Kreitmen RJ, Pastan I, Hsu SM, Epstein J. Significance of inducible IL-6 gene expression by myeloma cells. Blood 1991;78:105a (supplement, abstract).
4. Taguchi T, McGhee JR, Coffman RL, Beagley KW, Eldridge JH, Takatsu K, Kiyono H. Detection of individual mouse splenic T cells producing IFN-gamma and IL-5 using the enzyme-linked immunospot (ELISPOT) assay. J Immunol Methods 1990;128:65-73.
5. Caligaris-Cappio F, Bergui L, Gregoretti MG, Gaidano G, Gaboli M, Schena M, Zallone AZ, Marchisio PC. Role of bone marrow stromal cells in the growth of human multiple myeloma. Blood 1991;77:2688-2693.
6. Klein B, Wijdenes J, Zhang XG, Jourdan M, Boiron JM, Brochier J, Liautard J, Merlin M, Clement C, Morel-Fournier B, Lu ZY, Mannoni P, Sany J, Bataille R. Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood 1991;78:1198-1204.
7. Greipp PR, Raymond NM, Kyle RA, O'Fallon WM. Multiple myeloma significance of plasmablastic subtype in morphological classification. Blood 1985;65:305-310.
8. Kawano MM, Huang N, Harada H, Harada Y, Sakai A, Tanaka H, Iwato K, Kuramoto A. Identification of immature and mature myeloma cells in the bone marrow of human myelomas. Blood 1993;82:564-570.
9. Huang N, Kawano MM, Harada H, Harada Y, Sakai A, Kuramoto A, Niwa O. Heterogeneous expression of a novel MPC-1 antigen on myeloma cells: possible involvment of MPC-1 antigen in mature myeloma cells to bone marrow stromal cells. Blood 1993;82:3721-3729.
10. Durie BMG, Salmon SE. A clinical staging system for multiple myeloma. Cancer 1975;36:842-854.
11. Harada H, Kawano MM, Huang N, Harada Y, Iwato K, Tanabe O, Tanaka H, Sakai A, Asaoku H, Kuramoto A. Phenotypic difference of normal plasma cells from mature myeloma cells. Blood 1993;81:2658-2663.
12. + is the common phenotype of myeloma cells. Ann Hematol 1992;64:132-139.
13. Van Camp B, Durie BG, Spier C, De-Waele M, Van-Riet I, Vela E, Frutiger Y, Richter L, Grogan TM. Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19). Blood 1990;76:377-382.
14. Van Riet I, De-Waele M, Remels L, Lacor P, Schots R, Van Camp B. Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cells. Br J Haematol 1991;79:421-427.
15. Nilsson K., Jemberg H, Pettersson M. IL-6 as a growth factor for human myeloma cells. A short overview. Curr Top Microbiol Immunol 1990;166:3-5.
16. Levy Y, Tsapis A, Brouet JC. Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines. J Clin Invest 1991;88:696-699.
17. Schwab G, Siegall CB, Aarden LA, Neckers LM, Nordan RP. Characterization of an interleukin-6-mediated autocrine loop in the human multiple myeloma cell line, U266. Blood 1991;77:587-593.
18. Kawano MM, Mihara K, Huang N, Tsujimoto T, Kuramoto A. Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis. Blood 1995;85:487-494.
19. Aarden LA, de Groot ER, Schaap OL, Lansdorp PM. Production of hybridoma growth factor by human monocytes. Eur J Immunol 1987;17:1411-1416.
20. Hata H, Xiao H, Petrucci MT, Woodliff J, Chang R, Epstein J. Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells. Blood 1993;81:3357-3364.
21. Uchiyama H, Barut BA, Mohrbacher AF, Chauhan D, Anderson KC. Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion. Blood 1993;82:3712-3720.
22. Chen-Kiang S, Hsu W, Hatkunam Y, Zhang X. Nuclear signaling by interleukin-6. Curr Opin Immunol 1993;5:124-128.
23. Kishimoto T, Taga T, Akira S. Cytokine signal transduction. Cell 1994;76:253-262.